Raquel Brañas Casas

Dr. Raquel Brañas Casas

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2024 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
Raquel Brañas CasasRaquel Brañas Casas
Raquel Brañas Casas
AZAlessandro Zuppardo
Alessandro Zuppardo
GRGiovanni Risato
Giovanni Risato
ADAlberto Dinarello
Alberto Dinarello
RCRudy Celeghin
Rudy Celeghin
Natascia TisoNatascia Tiso
Natascia Tiso
The human mitochondrial DNA polymerase gamma is a holoenzyme, involved in mitochondrial DNA (mtDNA) replication and maintenance, composed of a catalytic subunit (POLG) and a dimeric accessory subunit (POLG2) conferring processivity. Mutations in POLG or POLG2 cause POLG-related diseases in humans, leading to a subset of Mendelian-inherited mitochondrial disorders characterized by mtDNA depletion (MDD) or accumulation of multiple deletions, presenting multi-organ defects and often leading to premature death at a young age. Considering the paucity of POLG2 models, we have generated a stable zebrafish polg2 mutant line (polg2ia304) by CRISPR/Cas9 technology, carrying a 10-nucleotide deletion with frameshift mutation and premature stop codon. Zebrafish polg2 homozygous mutants present slower development and decreased viability compared to wild type siblings, dying before the juvenile stage. Mutants display a set of POLG-related phenotypes comparable to the symptoms of human patients affected by POLG-related diseases, including remarkable MDD, altered mitochondrial network and dynamics, and reduced mitochondrial respiration. Histological analyses detected morphological alterations in high-energy demanding tissues, along with a significant disorganization of skeletal muscle fibres. Consistent with the last finding, locomotor assays highlighted a decreased larval motility. Of note, treatment with the Clofilium tosylate drug, previously shown to be effective in POLG models, could partially rescue MDD in Polg2 mutant animals. Altogether, our results point at zebrafish as an effective model to study the etiopathology of human POLG-related disorders linked to POLG2, and a suitable platform to screen the efficacy of POLG-directed drugs in POLG2-associated forms.

27 July 2024 in Cells
Verified
Journal Article
Open access
PDF file
GRGiovanni Risato
Giovanni Risato
Raquel Brañas CasasRaquel Brañas Casas
Raquel Brañas Casas
MCMarco Cason
Marco Cason
MMMaria Bueno Marinas
Maria Bueno Marinas
SPSerena Pinci
Serena Pinci
RCRudy Celeghin
Rudy Celeghin
Arrhythmogenic cardiomyopathy (AC) is a hereditary cardiac disorder characterized by the gradual replacement of cardiomyocytes with fibrous and adipose tissue, leading to ventricular wall thinning, chamber dilation, arrhythmias, and sudden cardiac death. Despite advances in treatment, disease management remains challenging. Animal models, particularly mice and zebrafish, have become invaluable tools for understanding AC’s pathophysiology and testing potential therapies. Mice models, although useful for scientific research, cannot fully replicate the complexity of the human AC. However, they have provided valuable insights into gene involvement, signalling pathways, and disease progression. Zebrafish offer a promising alternative to mammalian models, despite the phylogenetic distance, due to their economic and genetic advantages. By combining animal models with in vitro studies, researchers can comprehensively understand AC, paving the way for more effective treatments and interventions for patients and improving their quality of life and prognosis.

26 June 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
GRGiovanni Risato
Giovanni Risato
Raquel Brañas CasasRaquel Brañas Casas
Raquel Brañas Casas
MCMarco Cason
Marco Cason
MMMaria Bueno Marinas
Maria Bueno Marinas
SPSerena Pinci
Serena Pinci
RCRudy Celeghin
Rudy Celeghin
Arrhythmogenic cardiomyopathy (AC) is a hereditary cardiac disorder characterized by the gradual replacement of cardiomyocytes with fibrous and adipose tissue, leading to ventricular wall thinning, chamber dilation, arrhythmias, and sudden cardiac death. Despite advances in treatment, disease management remains challenging. Animal models, particularly mice and zebrafish, have become invaluable tools for understanding AC's pathophysiology and testing potential therapies. Mice models, although useful for scientific research, cannot fully replicate the complexity of the human AC. However, they have provided valuable insights into gene involvement, signalling pathways, and disease progression. Zebrafish offer a promising alternative to mammalian models, despite the phylogenetic distance, due to their economic and genetic advantages. By combining animal models with in vitro studies, researchers can comprehensively understand AC, paving the way for more effective treatments and interventions for patients and improving their quality of life and prognosis.

26 November 2025 in Research Square
Verified
Preprint
Open access
PDF file
KPKalliopi Pilichou
Kalliopi Pilichou
GRGiovanni Risato
Giovanni Risato
RCRudy Celeghin
Rudy Celeghin
MCMarco Cason
Marco Cason
MMMaria Bueno Marinas
Maria Bueno Marinas
Natascia TisoNatascia Tiso
Natascia Tiso
Galectin-3 (LGALS3/Gal-3) dysregulation has emerged as a critical mediator of inflammatory processes in arrhythmogenic cardiomyopathy (AC), playing pivotal roles in modulating Wnt/β-catenin signaling and regulating macrophage polarization. AC is a rare genetic disorder, primarily driven by desmosomal gene variants, characterized by fibro-fatty replacement of the ventricular myocardium, progressive ventricular dysfunction, and heightened arrhythmic risk in the young and athletes. To investigate the role of this multifaceted lectin in AC pathogenesis, we developed and characterized a stable lgals3a knock-out zebrafish model. Gal-3 deficiency alone was sufficient to recapitulate hallmark AC features, including ventricular adipose infiltration, chamber dilation, pericardial effusion, and progressive arrhythmias, spanning from larval to adult stages. Ultrastructural analyses revealed disrupted desmosomes, directly implicating Gal-3 in intercellular adhesion independent of other desmosomal gene variants. Transcriptomic analyses demonstrated suppression of both Wnt/β-catenin and TGFβ signaling. Early-stage pharmacological activation of Wnt signaling partially rescued cardiac function, but structural defects persisted in adults, indicating irreversible desmosomal instability. Inflammatory profiling revealed significant immune cell infiltration and upregulation of macrophage-related proinflammatory genes (e.g., MMP12, CCL38, IL16), consistent with AC “hot phases.” This study establishes Gal-3 depletion as a sufficient driver of AC-like pathology and identifies Gal-3–related pathways as promising targets for therapeutic intervention.

24 June 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GRGiovanni Risato
Giovanni Risato
RCRudy Celeghin
Rudy Celeghin
MCMarco Cason
Marco Cason
MMMaria Bueno Marinas
Maria Bueno Marinas
SPSerena Pinci
Serena Pinci
KPKalliopi Pilichou
Kalliopi Pilichou
Galectin-3 (Gal-3) dysregulation has emerged as a critical mediator of inflammatory processes in arrhythmogenic cardiomyopathy (AC), playing pivotal roles in modulating Wnt/β-catenin signaling and regulating macrophage polarization. AC is a rare genetic disorder, primarily driven by desmosomal gene variants, characterized by fibro-fatty replacement of the ventricular myocardium, progressive ventricular dysfunction, and heightened arrhythmic risk in the young and athletes. To investigate the role of this multifaceted lectin in AC pathogenesis, we developed and characterized a stable lgals3a (-aa) knock-out zebrafish model. lgals3a deficiency recapitulated several AC-like pathological features, including ventricular adipose infiltration, chamber dilation, pericardial effusion, and rhythm abnormalities from larval to adult stages. Ultrastructural analyses revealed disrupted desmosomes, directly implicating Gal-3 in intercellular adhesion independent of other desmosomal gene variants. Transcriptomic analyses demonstrated suppression of both Wnt/β-catenin and TGFβ signaling. Early-stage pharmacological activation of Wnt signaling partially rescued cardiac function, whereas structural defects persisted in adults, indicating that therapeutic efficacy is strongly dependent on disease stage and timing of intervention. Inflammatory profiling revealed significant immune cell infiltration and upregulation of macrophage-related proinflammatory genes (i.e., mmp25b and il12rb2), consistent with AC “hot phases”. This study revealed lgals3a deficiency as a contributor to AC-like pathological features in zebrafish and supports a role for Gal-3 in maintaining cardiac intercellular adhesion, inflammatory homeostasis, and cardiac function.